An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting (Q57278975)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1997

Language	Label	Description	Also known as
English	An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting	scientific article published on 01 January 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

I T Jantunen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T T Muhonen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

66-74

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary serotonin metabolite excretion during cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The 5-hydroxytryptamine receptor antagonists as antiemetics: preclinical evaluation and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Are all 5-HT3 receptor antagonists the same?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy: effects of antiemetics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. The Ondansetron Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Methylprednisolone versus Metoclopramide for Prevention of Nausea and Vomiting in Breast Cancer Patients Treated with Intravenous Cyclophosphamide Methotrexate 5-Fluorouracil: A Double-Blind Randomized Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective Control of CMF-Related Emesis with High-Dose Dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Methodology of antiemetic trials: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron versus metoclopramide as antiemetic treatment during cisplatin-based chemotherapy. A prospective study with special regard to regard to electrolyte imbalance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Dexamethasone plus ondansetron versus dexamethasone plus alizapride in the prevention of emesis induced by cisplatin-containing chemotherapies for urological cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of ondansetron plus dexamethasone in fractionated chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of Ondansetron with Customary Treatment in the Prophylaxis of Nausea and Emesis Induced by Non-Cisplatin Containing Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral ondansetron in the prevention of chemotherapy-induced emesis in breast cancer patients. French Ondansetron Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900276-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(96)00276-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071902%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57278975&oldid=2128741584"